Maximizing therapeutic gain with gemcitabine and fractionated radiation

This publication has 30 references indexed in Scilit:

• Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA doublestrand breaks as measured by pulsed-field gel electrophoresis
  International Journal of Radiation Biology, 1998
• Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model
  Radiation Oncology Investigations, 1997
• Radiosensitizing Nucleosides
  JNCI Journal of the National Cancer Institute, 1996
• Strain difference in jejunal crypt cell susceptibility to radiationinduced apoptosis
  International Journal of Radiation Biology, 1996
• Schedule-dependent therapeutic efficacy of the combination of gemcitabine and cisplatin in head and neck cancer xenografts
  European Journal Of Cancer, 1995
• Preclinical characteristics of gemcitabine
  Anti-Cancer Drugs, 1995
• Apoptosis in murine tumors treated with chemotherapy agents
  Anti-Cancer Drugs, 1995
• Head and Neck Cancer
  New England Journal of Medicine, 1993
• Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer
  New England Journal of Medicine, 1991
• 2',2'-Difluorodeoxycytidine Metabolism and Mechanism of Action In Human Leukemia Cells
  Nucleosides, Nucleotides and Nucleic Acids, 1989